Skip to main content

Table 5 The final liver parameters and serum C-reactive protein (CRP) in the five study groups

From: Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high-fructose-intake-associated metabolic syndrome

  LW
(gm)
LW/BW (gm/gm) ALT
(U/L)
Albumin (gm/ml) Bilirubin (mg/dl) MDA
(nmol /gm)
CRP
(ng/ml)
C 5.35±0.27
(10)
0.0272
±0.00096(10)
29.56±1.74
(9)
5.19±0.13
(9)
0.54±0.09
(9)
38.23±2.83
(9)
0.28±0.05
(9)
MS 8.13±0.38a
(14)
0.0419±
0.00151a(14)
81.20±1.33a
(10)
3.68±0.14a
(10)
0.55±0.09
(10)
129.07±4.29a
(10)
1.20±0.11a
(10)
MSRD 6.21±0.31b
(12)
0.0313±
0.00109a,b (12)
44.00±1.56a,b
(9)
4.45±0.12a,b
(9)
0.48±0.06
(9)
68.90±5.73a,b
(9)
0.50±0.07b
(9)
MSF 5.21±0.19b,c
(13)
0.0345±
0.00063a,b (13)
38.22±1.78a,b,c
(9)
4.51±0.14a,b
(9)
0.49±0.07
(9)
55.99±4.79a,b,c
(9)
0.40±0.07b
(9)
MSRDF 4.25±0.31a,b,c,d
(12)
0.0283±
0.00141b,d (12)
33.67±1.77b,c
(9)
4.77±0.17a,b
(9)
0.47±0.06
(9)
51.14±3.61a,b,c
(9)
0.33±0.05b
(9)
  1. C, control group, MS, untreated metabolic syndrome group, MSRD, metabolic syndrome group reverted to regular rat chow, MSF, metabolic syndrome group on alternate day fasting, MSRDF, metabolic syndrome group reverted to regular rat chow and on alternate day fasting; LW, liver weight; LW/BW, liver weight/body weight; ALT , serum alanine transferase; MDA, malondialdehyde content of liver tissue
  2. Data are expressed as mean ± SEM
  3. In the parenthesis is the number of observations
  4. a: Significance from control group, by LSD test at P ≤0.05
  5. b: Significance from MS group, by LSD test at P ≤0.05
  6. c: Significance from MSRD group, by LSD test at P ≤0.05
  7. d: Significance from MSF group, by LSD test at P ≤0.05